Atherosclerosis and Lipoproteins |
From the Department of Clinical Cell Biology, F5 (K. Taira, S.H., T.K, K. Takahashi, Y.S.), the Department of Genome Research and Clinical Application, M6 (H.B.), Graduate School of Medicine, and the Laboratory of Clinical Pharmacology (I.I.), Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan; Kowa Research Institute (H.Y.), Kowa Co Ltd, Tokyo, Japan; the Clinical Laboratory (T.M.), Niigata University School of Medicine, Niigata, Japan; and the Department of Molecular Genetics (S.H., W.J.S.), Biocenter and University of Vienna, Vienna, Austria.
Correspondence to Dr Hideaki Bujo, Department of Genome Research and Clinical Application, M6, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail hbujo{at}intmed02.m.chiba-u.ac.jp
Abstract Since the molecular identification of the low density lipoprotein receptor (LDLR), an ever increasing number of related proteins have been discovered. These receptors belonging to the LDLR family are thought to play key roles in lipoprotein metabolism in a variety of tissues, including the arterial wall. We have discovered that the expression of a 250-kDa mosaic LDLR-related protein, which we termed LR11 for the presence of 11 LDLR ligandbinding repeats, is markedly induced in smooth muscle cells in the hyperplastic intima of animal models used for the study of atherosclerosis. Here, we demonstrate that the human LR11, when overexpressed in hamster cells, binds and internalizes 39-kDa receptorassociated protein (RAP), an in vitro ligand for all receptors belonging to the LDLR family. Furthermore, LR11 binds the apolipoprotein E (apoE)-rich lipoproteins, ß-very low density lipoproteins (VLDLs), with a high affinity similar to that of other members, such as the LDLR and VLDL receptor. RAP and ß-VLDL compete with each other; however, other serum lipoproteins are not able to inhibit their binding. LR11 shows specific binding of apoE-enriched HDL prepared from human cerebrospinal fluid as well as of ß-VLDL, suggesting that the apoE content of lipoproteins is most likely important for mediating the high-affinity binding to the receptor. LR11-overexpressing cells are able to internalize and degrade the bound ß-VLDL; these cells also show increased accumulation of cholesteryl esters when incubated with ß-VLDL. Incubation for 48 hours with ß-VLDL of LR11-overexpressing cells, but not of control cells, promotes the appearance of numerous intracellular lipid droplets. Taken together, LR11, a mosaic LDLR family member whose expression in smooth muscle cells is markedly induced in atheroma, has all the properties of a receptor for the endocytosis of lipoproteins, particularly for the incorporation of apoE-rich lipoproteins.
Key Words: LDL receptors atherosclerosis smooth muscle cells ß-VLDL
This article has been cited by other articles:
![]() |
M. Matsuo, H. Ebinuma, I. Fukamachi, M. Jiang, H. Bujo, and Y. Saito Development of an Immunoassay for the Quantification of Soluble LR11, a Circulating Marker of Atherosclerosis Clin. Chem., October 1, 2009; 55(10): 1801 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kolovou, D. Damaskos, K. Anagnostopoulou, and D. V. Cokkinos Apolipoprotein E Gene Polymorphism and Gender Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 120 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, C. C. van der Hoogt, S. M. S. Espirito Santo, R. Out, K. E. Kypreos, B. J. M. van Vlijmen, T. J. C. Van Berkel, J. A. Romijn, L. M. Havekes, K. W. van Dijk, et al. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI J. Lipid Res., July 1, 2008; 49(7): 1553 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nielsen, C. Gustafsen, P. Madsen, J. R. Nyengaard, G. Hermey, O. Bakke, M. Mari, P. Schu, R. Pohlmann, A. Dennes, et al. Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA Mol. Cell. Biol., October 1, 2007; 27(19): 6842 - 6851. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Ting, J. P. Stice, U. Y. Schaff, D. Y. Hui, J. C. Rutledge, A. A. Knowlton, A. G. Passerini, and S. I. Simon Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-{alpha} Circ. Res., February 16, 2007; 100(3): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bohm, N. M. Seibel, B. Henkel, H. Steiner, C. Haass, and W. Hampe SorLA Signaling by Regulated Intramembrane Proteolysis J. Biol. Chem., May 26, 2006; 281(21): 14547 - 14553. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rezgaoui, U. Susens, A. Ignatov, M. Gelderblom, G. Glassmeier, I. Franke, J. Urny, Y. Imai, R. Takahashi, and H. C. Schaller The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37 J. Cell Sci., February 1, 2006; 119(3): 542 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Offe, S. E. Dodson, J. T. Shoemaker, J. J. Fritz, M. Gearing, A. I. Levey, and J. J. Lah The Lipoprotein Receptor LR11 Regulates Amyloid beta Production and Amyloid Precursor Protein Traffic in Endosomal Compartments J. Neurosci., February 1, 2006; 26(5): 1596 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spoelgen, C. A. F. von Arnim, A. V. Thomas, I. D. Peltan, M. Koker, A. Deng, M. C. Irizarry, O. M. Andersen, T. E. Willnow, and B. T. Hyman Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and beta-Secretase beta-Site APP-Cleaving Enzyme J. Neurosci., January 11, 2006; 26(2): 418 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. S. E. Santo, P. C. N. Rensen, J. R. Goudriaan, A. Bensadoun, N. Bovenschen, P. J. Voshol, L. M. Havekes, and B. J. M. van Vlijmen Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice J. Lipid Res., June 1, 2005; 46(6): 1097 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kzhyshkowska, A. Gratchev, J.-H. Martens, O. Pervushina, S. Mamidi, S. Johansson, K. Schledzewski, B. Hansen, X. He, J. Tang, et al. Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors J. Leukoc. Biol., December 1, 2004; 76(6): 1151 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, P. Fan, E. Shimoji, H. Xu, K. Takeuchi, C. Bian, and K. Saku Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E-Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1910 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaga, H. Bujo, Y. Zhu, T. Kanaki, S. Hirayama, K. Takahashi, M. Inoue, K. Mikami, W. J. Schneider, and Y. Saito LRP1B Attenuates the Migration of Smooth Muscle Cells by Reducing Membrane Localization of Urokinase and PDGF Receptors Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1422 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, H. Bujo, H. Yamazaki, K. Ohwaki, M. Jiang, S. Hirayama, T. Kanaki, M. Shibasaki, K. Takahashi, W. J. Schneider, et al. LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell Migration Circ. Res., April 2, 2004; 94(6): 752 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-A. Gutekunst, E. R. Torre, Z. Sheng, H. Yi, S. H. Coleman, I. B. Riedel, and H. Bujo Stigmoid Bodies Contain Type I Receptor Proteins SorLA/LR11 and Sortilin: New Perspectives on Their Function J. Histochem. Cytochem., June 1, 2003; 51(6): 841 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kolovou, D. Daskalova, and D. P. Mikhailidis Apolipoprotein E Polymorphism and Atherosclerosis Angiology, January 1, 2003; 54(1): 59 - 71. [Abstract] [PDF] |
||||
![]() |
Y. Zhu, H. Bujo, H. Yamazaki, S. Hirayama, T. Kanaki, K. Takahashi, M. Shibasaki, W. J. Schneider, and Y. Saito Enhanced Expression of the LDL Receptor Family Member LR11 Increases Migration of Smooth Muscle Cells In Vitro Circulation, April 16, 2002; 105(15): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |